Artemisinin-based antimalarial medicines available for procurement by WHO

(Last updated 02.03.2011) International Non-Proprietary Name (INN) of product Artemether / lumefantrine Strength 20mg/120mg Dosage form Fixed dose tablets Supplier Ajanta, India Presentation 6x1 6x2 6x3 6x4 6x1 6x2 6x3 6x4 6x1 6x2 6x3 6x4 6x1 6x2 6x3 6x4 6x1 dispersible 6x2 dispersible 3 6 12 3 3 3 6 3+3 6+6 12+12 3 6 12 3+3 6+6 12+12 3+3 6+6 12+12 3+6 3+1 6+2 12+3 3+1 6+2 6+3 Vial Packaging 30 blisters / box

Cipla, India

Ipca, India

Novartis, China/USA

Novartis, USA 40mg/240mg Fixed dose tablets Cipla, India

Artesunate + amodiaquine

25mg+67.5mg 50mg+135mg 100mg+270mg 100mg+270mg 50mg + 150mg (base)

Fixed dose tablets

Sanofi Aventis

3 tablets / pack 6 tablets / pack 12 tablets / pack 25 blisters / box

Co-blistered tablets

Guilin, China

25 blisters / box

50mg + 153mg

Fixed dose tablets

20 blisters / box

50mg + 153mg (base)

Co-blistered tablets

Cipla, India

25 blisters / box

Strides, India

10 treatments / box

Artesunate + mefloquine Artesunate + sulfadoxine / pyrimethamine

200mg + 250mg 50mg + 500/25mg

Co-blistered tablets Co-blistered tablets

Mepha, Switzerland Cipla, India

Single blisters Single blisters

Guilin, China 100mg + 500/25mg Artesunate 60 mg + diluent Powder for injection Guilin, China

25 blisters / box

Pack of 5

WHO prequalified products (last updated 01.02.2011)